SCHEMBL461674

SCHEMBL461674

C=CCC1(C(N)=O)CCC(N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152526 0.89
SCHEMBL6063404 0.79 CYP2C19 (0.31)
SCHEMBL23539431 0.74 ALDH1A1 (0.31)
SCHEMBL7038806 0.74 CYP2C19 (0.34)
SCHEMBL7274953 0.73 CYP4F2 (0.34)
SCHEMBL11765654 0.71 CYP2C19 (0.36)
SCHEMBL27263967 0.68
SCHEMBL6802128 0.68 GNAI3 (0.32)
SCHEMBL10695833 0.67
SCHEMBL1543252 0.66 ARG1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022113-A1 METHODS FOR SUPPRESSING TIPDC TRAFFICKING OR ACCUMULATION AND PREVENTING HYPERCYTOKINEMIA NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-01-26 US disclosed
WO-2010085385-A1 METHODS FOR SUPPRESSING TIP DC TRAFFICKING OR ACCUMULATION AND PREVENTING HYPERCYTOKINEMIA ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2010-07-29 WO disclosed